Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-11-26–present
-
Current
2021-11-26–present
-
Current
2021-01-01–present
-
Current
-
2024-01-10–2025-08-14
-
Start not stated–2025-08-14
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
CEO, Chairman, Board Member
2021-01-01–present
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | SeaStar Medical Holding Corp (ICU) | Chief Financial Officer (former) | $231,250 | $253,750 |
| 2024 | SeaStar Medical Holding Corp (ICU) | Chief Financial Officer | $363,702 | $762,152 |
| 2023 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Former Chief Executive Officer | $6,566 | $4,567,862 |
| 2022 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Former Chief Executive Officer | $35,568 | $37,152 |
| 2021 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Chief Executive Officer | $35,568 | $258,539 |
| 2020 | Harvard Apparatus Regenerative Technology, Inc. (HRGN) | Interim Chief Executive Officer | — | — |
| 2019 | Aytu Biopharma, Inc (AYTU) | Former Chief Financial Officer, Secretary and Treasurer, | $250,000 | $685,988 |
| 2018 | Aytu Biopharma, Inc (AYTU) | Chief Financial Officer, Secretary and Treasurer, since December 2017 | $135,000 | $287,000 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.